The strategic appointment will drive Amplexor's next phase of growth, exploiting Ms Hudson's combined clinical and commercial industry experience. Ms Hudson, who joined the group in September, will spearhead Amplexor International's sales operations within the Life Sciences Industry, with responsibility for global sales teams. She brings to the role deep experience in senior clinical research as well as commercial roles across the life sciences industry.
In addition to her many years in the industry, Ms Hudson boasts highly desirable hybrid skills as a global life sciences executive, thanks to 11 years in commercial roles at Genentech early in her career (e.g. product management, and sales management for which she won multiple awards), followed by senior roles in clinical research. She was retained in this capacity to run the CRO for the Mayo Clinic ( Mayo Clinical Trial Services) and later ran the Oklahoma Heart Hospital Research Foundation where she was executive director and senior VP for clinical research.
Ms Hudson is an ideal fit in her new role, with sales experience that includes drugs/biologics, medical devices, and clinical trial technologies. She is experienced in working with clinical research and commercial teams across Pharma, Biotech, device and CRO clients and she understands the needs and challenges of global life science, product development.
She holds a Bachelor of Science in Occupational Therapy, gained at the University of Illinois and a Masters of Business Administration, with a concentration in marketing, from Benedictine University in Lisle, Illinois.
Commenting on her appointment, Ms Hudson said, "I relish this new challenge, and am delighted to have joined the team. There is a huge opportunity for Amplexor in the global Life Sciences market taking advantage of our product offerings in IT solutions and translation services to enable our client's product development. The brand has a strong reputation here, so it is a privilege to be on board and I am looking forward to spearheading the next stage in the group's growth on both sides of the Atlantic."
Welcoming her to the Amplexor fold, Elvis Pacelat, VP Compliance Management at Amplexor, said, "Bev is a very strong addition to the Amplexor family. She is steeped in experience on both sides of the industry, which sets her in very good stead to understand the needs of our global clients and match them to our wide range of solutions and services. She appreciates perfectly where each offering fits, and the benefits that are possible. I am delighted our sales operations will be in such good hands."